Science Explorer Back to mapMap
Discussion
Company · Cambridge · United States

Merrimack Pharmaceuticals (United States)

World rank, all time
#19,471
of 34,923
Rank in United States
#4,039
of 7,310
Research works
228
▼ 88% vs 2018-21
Citations
5.9k
25.8 per fractional work
Top-10% rate
8.2%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
23%
world 40%
International
12%
world 18%

Which fields of science does Merrimack Pharmaceuticals (United States) work in?

In all years, 48% of research at Merrimack Pharmaceuticals (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (5%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 109 fractional works · 47.9% of its workMedicine: 108 fractional works · 47.3% of its workOncology: 43 fractional works · 19.1% of its workRadiology, Nuclear Medicine and Imaging: 30 fractional works · 13.2% of its workPulmonary and Respiratory Medicine: 11 fractional works · 4.9% of its workGenetics: 2 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 0.8% of its workPharmacology: 2 fractional works · 0.8% of its workEpidemiology: 2 fractional works · 0.8% of its workSurgery: 2 fractional works · 0.8% of its workPhysiology: 2 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 0.7% of its workInfectious Diseases: 1 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.5% of its workImmunology and Allergy: 1 fractional works · 0.4% of its workRheumatology: 1 fractional works · 0.4% of its workReproductive Medicine: 1 fractional works · 0.4% of its workPsychiatry and Mental health: 1 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 0.3% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workLife Sciences: 73 fractional works · 32.0% of its workBiochemistry, Genetics and Molecular Biology: 57 fractional works · 25.1% of its workMolecular Biology: 42 fractional works · 18.4% of its workCancer Research: 7 fractional works · 3.2% of its workBiotechnology: 4 fractional works · 1.6% of its workGenetics: 2 fractional works · 0.7% of its workCell Biology: 2 fractional works · 0.7% of its workBiophysics: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workImmunology and Microbiology: 12 fractional works · 5.1% of its workImmunology: 11 fractional works · 4.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 2 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.3% of its workPharmacology: 1 fractional works · 0.3% of its workPhysical Sciences: 39 fractional works · 17.2% of its workEngineering: 11 fractional works · 4.8% of its workBiomedical Engineering: 4 fractional works · 1.9% of its workElectrical and Electronic Engineering: 2 fractional works · 0.8% of its workMechanical Engineering: 1 fractional works · 0.5% of its workBuilding and Construction: 1 fractional works · 0.4% of its workAerospace Engineering: 1 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.8% of its workMaterials Science: 10 fractional works · 4.3% of its workBiomaterials: 8 fractional works · 3.4% of its workMaterials Chemistry: 2 fractional works · 0.7% of its workGeneral Materials Science: 0 fractional works · 0.2% of its workComputer Science: 7 fractional works · 3.3% of its workComputational Theory and Mathematics: 7 fractional works · 3.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 4 fractional works · 1.8% of its workSpectroscopy: 1 fractional works · 0.6% of its workAnalytical Chemistry: 1 fractional works · 0.6% of its workOrganic Chemistry: 1 fractional works · 0.3% of its workPhysical and Theoretical Chemistry: 1 fractional works · 0.3% of its workPhysics and Astronomy: 2 fractional works · 1.1% of its workAstronomy and Astrophysics: 1 fractional works · 0.5% of its workStatistical and Nonlinear Physics: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 2 fractional works · 0.7% of its workMathematics: 1 fractional works · 0.6% of its workModeling and Simulation: 1 fractional works · 0.3% of its workStatistics and Probability: 1 fractional works · 0.3% of its workChemical Engineering: 1 fractional works · 0.5% of its workFiltration and Separation: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 7 fractional works · 2.9% of its workSocial Sciences: 4 fractional works · 1.7% of its workPolitical Science and International Relations: 2 fractional works · 0.7% of its workSociology and Political Science: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.6% of its workBusiness, Management and Accounting: 2 fractional works · 0.7% of its workManagement of Technology and Innovation: 2 fractional works · 0.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.5% of its workEconomics and Econometrics: 1 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKMerrimackPharmaceuticals…228fractional works, all years
Life Sciences32%Physical Sciences17%Health Sciences48%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine10847.3%
    2. Health Professions10.3%
    3. Nursing10.3%
    1. Biochemistry, Genetics and Molecular Biology5725.1%
    2. Immunology and Microbiology125.1%
    3. Neuroscience21.0%
    4. Agricultural and Biological Sciences10.5%
    5. Pharmacology, Toxicology and Pharmaceutics10.3%
    1. Engineering114.8%
    2. Materials Science104.3%
    3. Computer Science73.3%
    4. Chemistry41.8%
    5. Physics and Astronomy21.1%
    6. Environmental Science20.7%
    7. Mathematics10.6%
    8. Chemical Engineering10.5%
    9. Earth and Planetary Sciences00.1%
    1. Social Sciences41.7%
    2. Business, Management and Accounting20.7%
    3. Economics, Econometrics and Finance10.5%
    4. Psychology00.1%
    5. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.13× its world share, 2 worksBiochemistry, Geneti…Engineering: 0.51× its world share, 0 worksEngineeringEnvironmental Science: 0.77× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.54× its world share, 0 worksMaterials ScienceHealth Professions: 1.15× its world share, 0 worksHealth ProfessionsMedicine: 1.50× its world share, 1 worksMedicineSocial Sciences: 1.32× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.1×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology7.13×2 works
  2. Medicine1.50×1 works
  3. Social Sciences1.32×1 works
  4. Health Professions1.15×0 works
  5. Environmental Science0.77×0 works
  6. Materials Science0.54×0 works
  7. Engineering0.51×0 works

Who are the top researchers at Merrimack Pharmaceuticals (United States)?

Ranked on the quality score, Daryl C. Drummond, Ashish V. Kalra and Jonathan B. Fitzgerald lead among researchers whose main affiliation is Merrimack Pharmaceuticals (United States).

  1. 1 Daryl C. Drummond United States · #113,818 worldwide 10k citations · 205 works
  2. 2 Ashish V. Kalra United States · #114,636 worldwide 2.3k citations · 100 works
  3. 3 Jonathan B. Fitzgerald United States · #145,841 worldwide 3.4k citations · 148 works
  4. 4 Alexey A. Lugovskoy United States · #147,035 worldwide 8k citations · 118 works
  5. 5 Bart S. Hendriks United States · #291,839 worldwide 3k citations · 115 works
  6. 6 Birgit Schoeberl United States · #312,357 worldwide 4.8k citations · 138 works
  7. 7 Jeffrey D. Kearns United States · #320,449 worldwide 2.3k citations · 68 works
  8. 8 Violette B. Paragas United States · #390,993 worldwide 2.6k citations · 55 works
  9. 9 Elena Geretti United States · #519,829 worldwide 1.9k citations · 70 works
  10. 10 Jason Baum United States · #540,579 worldwide 910 citations · 90 works
All ranked researchers at Merrimack Pharmaceuticals (United States)

What are the most cited papers from Merrimack Pharmaceuticals (United States)?

The most cited paper from Merrimack Pharmaceuticals (United States) is "Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial" (Andrea Wang‐Gillam et al., 2015), with 1,232 citations. Next come "Systems biology and combination therapy in the quest for clinical efficacy" (591) and "Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics" (478).

Most cited papers
#PaperReleasedCitations
1 Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial Andrea Wang‐Gillam et al. · The Lancet 29 Nov 2015 1,232
2 Systems biology and combination therapy in the quest for clinical efficacy Jonathan B. Fitzgerald, Birgit Schoeberl, Ulrik B. Nielsen et al. · Nature Chemical Biology 18 Aug 2006 591
3 Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics Manu P. Kumar, Jinyan Du, Georgia Lagoudas et al. · Cell Reports Open access Nov 2018 478
4 Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data William W. Chen, Birgit Schoeberl, Paul Jasper et al. · Molecular Systems Biology Open access 20 Jan 2009 407
5 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer Helen Lee, Anthony Frank Shields, Barry Alan Siegel et al. · Clinical Cancer Research Open access 15 Mar 2017 386
All 60 most cited papers, with filters and sorting

Which keywords describe research at Merrimack Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Monoclonal Antibodies, Breast Cancer, Therapeutic Antibodies, Antibody Engineering, Fc Receptors and Monoclonal Antibody.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy36▲ 22×14 topics
  2. Glycosylation32▲ 64×3 topics
  3. Monoclonal Antibodies25▲ 77×3 topics
  4. Breast Cancer25▲ 39×6 topics
  5. Therapeutic Antibodies25▲ 84×2 topics
  6. Antibody Engineering23▲ 102×1 topic
  7. Fc Receptors23▲ 102×1 topic
  8. Monoclonal Antibody22▲ 142×2 topics
  9. Receptor tyrosine kinases22▲ 222×2 topics
  10. Trastuzumab22▲ 222×2 topics
  11. Cancer21▲ 6.6×24 topics
  12. EGFR21▲ 301×1 topic
  13. HER221▲ 301×1 topic
  14. Cancer Therapy16▲ 11×12 topics
  15. Targeted Therapy15▲ 30×4 topics
  16. Immunotherapy15▲ 10×9 topics
  17. Tumor Targeting15▲ 48×3 topics
  18. Nanoparticles13▲ 4.3×7 topics
  19. Tumor Microenvironment10▲ 13×7 topics
  20. Clinical Trials10▲ 7.2×7 topics
  21. Magnetic Nanoparticles8▲ 35×2 topics
  22. Metabolism8▲ 5.5×6 topics
  23. Biomedical Applications8▲ 3.3×4 topics
  24. Metastatic Breast Cancer8▲ 52×2 topics
  25. Drug Delivery8▲ 7.2×3 topics
  26. Surface Engineering8▲ 30×2 topics
  27. Nanocarriers8▲ 77×1 topic
  28. Polymeric Nanoparticles8▲ 77×1 topic
  29. Immune System8▲ 10.0×2 topics
  30. Glycans7▲ 40×1 topic
  31. Mucins7▲ 40×1 topic
  32. Pharmacokinetics7▲ 11×3 topics
  33. Signaling7▲ 25×4 topics
  34. Medicinal Chemistry6▲ 7.3×4 topics
  35. Molecular Docking6▲ 18×1 topic
  36. Virtual Screening6▲ 37×1 topic
  37. Immunity6▲ 7.3×5 topics
  38. PET Imaging6▲ 11×4 topics
  39. ALK Inhibitors5▲ 42×1 topic
  40. EGFR Mutations5▲ 42×1 topic

Which research topics does Merrimack Pharmaceuticals (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Advanced biosensing and bioanalysis techniques, Lipid Membrane Structure and Behavior and RNA Interference and Gene Delivery.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  3. 3 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  4. 4 RNA Interference and Gene Delivery Molecular Biology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 African Studies and Geopolitics Anthropology 0 works
  8. 8 Healthcare and Environmental Waste Management Public Health, Environmental and Occupational Health 0 works
  9. 9 Multiculturalism, Politics, Migration, Gender Political Science and International Relations 0 works
  10. 10 Political and Social Issues Political Science and International Relations 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.0%not open77.0%

World: 40% of research is openly available.

with international co-authors11.8%domestic only88.2%

World: 18% is written across borders.

How has Merrimack Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 88% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Merrimack Pharmaceuticals (United States) as a percentage of every work published that year, 0.000055% in 2022.

0.0010%0.0020%Merrimack Pharmaceuticals (United States)0.000019% in 202319801990200020102020

Fractional works of Merrimack Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share Merrimack Pharmaceuticals (United States)'s ranking

Merrimack Pharmaceuticals (United States) on Science Explorer

A card with Merrimack Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Merrimack Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.